<!DOCTYPE html>
<html lang="en">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
		<meta name="viewport" content="width=device-width, initial-scale=1">
		<title></title>
		<link rel="stylesheet" href="css/dh.css" type="text/css">
		<link rel="stylesheet" href="css/animate.css" type="text/css">
		<script type="text/javascript" src="js/base.js">
</script>
		<script type="text/javascript" src="js/Common.js">
</script>
		<script type="text/javascript" charset="utf-8">


		ANIMATION = [
				
		   ];

		</script>
		<style type="text/css">
span.bold { font-family: "HelveticaBold"; }
		</style>
	</head>
	<body class="slide-3">
		<div id="content">
			<header>
				Status on the DHHS Guidelines for HIV-1 Infected Pregnant Women<sup>3,4</sup>
			</header>
			<div class="logo"></div>
			<section>
				<div class="header1">
					Adult treatment-na√Øve
				</div>
				<div class="header2">
					Pregnant women
				</div>
				<div class="chartbk">
					<div>
						<img onclick="makecall('PlainPopup',Array('dh-03-popup-01','Adult treatment','180','380','10','0','900','670','4','0'));" src="images/dh-03-chart1.jpg" width="340" height="218" alt="Chart1">
					</div>
					<div>
						<img src="images/dh-03-guidelines.jpg" width="174" height="243" alt="Guidelines">
					</div>
					<div>
						<img onclick="makecall('PlainPopup',Array('dh-03-popup-02','Pregnant Women','180','400','10','0','940','590','4','0'));" src="images/dh-03-chart2.jpg" width="341" height="220" alt="Chart2">
					</div>
					<div class="clear"></div>
				</div>
				<div class="safety">
					<p>
						<strong>Safety Considerations</strong>
					</p>
					<p class="bullet">
						KALETRA is Pregnancy Category C.
					</p>
					<p class="bullet">
						There are no adequate and well-controlled studies of KALETRA in pregnant women.
					</p>
					<p class="bullet">
						KALETRA should be used during pregnancy only if potential benefit justifies the potential risks to the fetus.
					</p>
					<p class="bullet">
						Mothers should be instructed <span class="bold">not to breast-feed if they are receiving KALETRA.</span>
					</p>
				</div>
				<div class="disc">
					<p>
						<strong>Antiretroviral Pregnancy Registry:</strong><br>
						To monitor maternal-fetal outcomes of pregnant women exposed to KALETRA, an Antiretroviral Pregnancy Registry has been established. Physicians are encouraged to register patients by calling 1-800-258-4263 or by going online to <span class="bold">apregistry.com</span>.
					</p>
				</div>
			</section>Antiretroviral Pregnancy Registry: To monitor maternal-fetal outcomes of pregnant women exposed to KALETRA, an Antiretroviral Pregnancy Registry has been established. Physicians are encouraged to register patients by calling 1-800-258-4263.
			<footer>
				Please click buttons above for Indication and Important Safety Information about KALETRA.
			</footer>
		</div>
	</body>
</html>